Chronic kidney disease is associated with increased all‐cause mortality in transvenous lead extraction: A systematic review and meta‐analysis

Background The impact of chronic kidney disease (CKD) or end‐stage renal disease (ESRD) on patients receiving transvenous lead extraction (TLE) is not well‐established. We performed a systematic review and meta‐analysis to explore the association between CKD and all‐cause mortality in TLE. Methods W...

Full description

Saved in:
Bibliographic Details
Published in:Pacing and clinical electrophysiology 2023-01, Vol.46 (1), p.66-72
Main Authors: Tan, Min Choon, Talaei, Fahimeh, Trongtorsak, Angkawipa, Lee, Justin Z., Rattanawong, Pattara
Format: Article
Language:English
Subjects:
chronic kidney disease
end‐stage renal disease
Humans
Kidney diseases
Kidney Failure, Chronic - complications
lead extraction
Meta-analysis
Mortality
outcome assessment
Renal Insufficiency, Chronic - complications
Risk Factors
Systematic review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background The impact of chronic kidney disease (CKD) or end‐stage renal disease (ESRD) on patients receiving transvenous lead extraction (TLE) is not well‐established. We performed a systematic review and meta‐analysis to explore the association between CKD and all‐cause mortality in TLE. Methods We searched the databases of PubMed and EMBASE from inception to April 2022. Included studies were published TLE studies that compared the risk of mortality in CKD patients compared to control patients. Data from each study were combined using the random‐effects model. Results Eight studies (5,013 patients) were included. Compared with controls, CKD patients had a significantly higher risk of overall all‐cause mortality (hazard ratio [HR] = 2.14, 95% confidence interval [CI]: 1.65–2.77, I2 = 51.1%, p 
ISSN:0147-8389
1540-8159
DOI:10.1111/pace.14631